Østfold Hospital Trust

Running trials

• Not yet recruiting

  Vi-Siblin for LARS: A randomized, controlled trial.

  2024-514541-11-00· Phase 2· Sykehuset Telemark HF· Source

• Not yet recruiting

  Vexus Assessment and Natriuresis-guided Diuretic Therapy in Acute Heart Failure

  NCT07558798· University Hospital, Akershus· Source

• Recruiting

  Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Trial - Holistic Study

  2023-505573-32-00· Phase 3· Ostfold Hospital Trust· Source

• Recruiting

  The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy

  NCT07040813· Phase 3· Oslo University Hospital· Source

• Recruiting

  Thrombolysis in Factor Xa-inhibitors Trial

  NCT06878066· Phase 3· Guri Hagberg· Source

• Recruiting

  Ketamine for depression and alcohol use disorder

  NCT06090422· Phase 1/2· University Hospital Of North Norway HF· Source

• Active, not recruiting

  Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcutaneous TNF inhibitor: The Rheumatoid Arthritis therapeutic DRUg Monitoring trial (RA-DRUM)

  2023-510184-35-00· Phase 4· Diakonhjemmet Sykehus AS· Source

• Active, not recruiting

  A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma

  NCT05625399· Phase 3· Bristol-Myers Squibb· Source

• Recruiting

  Genetic Study of Amyotrophic Lateral Sclerosis in Norway

  NCT05119387· Sykehuset Telemark· Source

• Recruiting

  ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

  NCT03903835· Phase 3· Karolinska Institutet· Source

• Active, not recruiting

  Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

  NCT02041845· Norwegian University of Science and Technology· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)1 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Depression1 recruiting
• Heart failure1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Melanoma1 recruiting
• Migraine1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Study to assess the safety, pharmacokinetics and efficacy of HMPL-523 in patients with Immune Thrombocytopenia

  2023-508819-23-00· Phase 1· Hutchmed Ltd.· Source

• Completed

  A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study

  2024-511560-93-00· Phase 3· Boehringer Ingelheim International GmbH· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

  NCT04812925· Phase 3· argenx· Source

• Completed

  Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

  NCT04562766· Phase 3· Principia Biopharma, a Sanofi Company· Source

• Completed

  The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

  NCT04122235· Sorlandet Hospital HF· Source

• Completed

  Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

  NCT03260894· Phase 3· Incyte Corporation· Source

• Completed

  The PROLONG Trial - Rituximab Maintenance Therapy in ITP

  NCT03010202· Phase 3· Ostfold Hospital Trust· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Immune thrombocytopenia (ITP)16 works · 5 trials